Endometriosis is a condition that develops when tissue similar to the uterine lining grows outside the uterus. This misplaced tissue may lead to persistent inflammation and scarring of reproductive organs. Some women experience apparent symptoms like severe cramps or painful periods, and others show little to no signs of having the condition. Here is information about silent endometriosis and when to test for it:
What Is Silent Endometriosis?
Silent endometriosis occurs when tissue similar to the uterine lining grows outside the uterus but doesn’t cause significant pain or discomfort. Inflammation is present inside, yet many women don’t experience severe cramps or pelvic discomfort. Silent endometriosis may go unnoticed for years because symptoms are mild or absent. This contrasts with typical endometriosis, which is often associated with pain during periods or sexual activity.
The condition sometimes causes progesterone resistance in the endometrium, promoting a more proliferative state that can interfere with embryo implantation. Specialists often discover the condition during in-depth fertility evaluations. During testing, doctors look for markers such as elevated BCL6 protein in the uterine lining; this can indicate inflammation linked to the condition.
When BCL6 is high, the uterus sometimes has a harder time supporting an embryo, whether in natural cycles or IVF. Small endometrial lesions and inflammation have the potential to disrupt the uterine lining’s receptivity. This can make it harder for an embryo to attach by creating a hostile environment with altered immune responses.
Who Should Test for It?
Women who are having trouble conceiving without a clear reason benefit from screening for silent endometriosis. Those experiencing repeated pregnancy loss are often advised to be tested, since hidden inflammation can affect outcomes. Previous unsuccessful fertility treatments sometimes point to silent endometriosis, especially when no other cause is found.
A family history of endometriosis may prompt a doctor or healthcare provider to recommend testing, as the condition has a genetic component. To identify whether testing is suitable, physicians examine menstrual patterns and reproductive history. Small growths or adhesions may be seen on imaging or laparoscopy, and identifying them helps with overall treatment planning.
The Best Practices for Offering White Label SEO Services to Your Clients
When Is the Test Completed?
Testing for silent endometriosis is scheduled after ovulation, when the uterine lining is prepared for a potential embryo. At this stage, BCL6 protein levels can indicate whether inflammation associated with endometriosis is present. Patients track ovulation at home using test kits, and this helps the clinic determine the optimal day for testing. The tissue sample, called a biopsy, is then collected by a healthcare provider at the clinic. Collecting the sample at the appropriate time supports accurate results.
How Does Testing Work?
An endometrial biopsy involves taking a small sample of the uterine lining to measure BCL6 levels. The procedure is performed in the doctor’s office, and it usually doesn’t require anesthesia, making it relatively quick. The lab then analyzes the sample to determine whether BCL6 levels suggest a strong likelihood of silent endometriosis.
This test can detect the condition before more invasive procedures are completed. Laparoscopy helps confirm the diagnosis. A positive result for markers like BCL6 may indicate silent endometriosis, and it can guide next steps, such as hormone therapy to reduce inflammation or surgery to treat lesions. A negative result helps rule out endometriosis. This allows doctors to focus on other possible fertility factors, such as hormonal imbalances.
Why Is Early Testing Ideal?
Silent endometriosis may interfere with embryo implantation and contribute to recurrent pregnancy loss or reduced success with assisted reproductive technology (ART) procedures. Early testing sometimes uncovers related issues, such as adhesions, allowing doctors to address them with minimally invasive procedures and improve the uterine environment. Results from hormone levels, inflammatory markers, and endometrial tests help physicians select treatments that match the underlying condition. The findings also indicate whether other causes of infertility should be investigated, potentially reducing unnecessary tests or treatments. After testing, physicians can monitor uterine health to assess how well it supports conception.
Learn More About BCL6 Testing
Testing for endometriosis helps reveal hidden inflammation, even when there are no obvious symptoms. An evaluation can provide information that guides appropriate fertility treatment decisions. Women experiencing unexplained infertility, recurrent pregnancy loss, or repeated IVF failures are able to use these insights to guide the next steps in their care. Contact a fertility specialist to discuss testing options for endometriosis.
